Mouse  

The Harry M. Zweig Memorial Fund for Equine Research


Don't Miss!

 

The Triple Crown:

The Kentucky Derby May 4, 2013

The Preakness Stakes May 18, 2013

The Belmont Stakes June 8, 2013

The Travers Stakes - Saratoga Springs, NY, August 24, 2013

Harry M. Zweig Memorial Trot- Vernon Downs, August 25, 2013

The Breeders' Cup - Santa Anita Arcadia, California - November 1 & 2, 2013

Join our mailing list!

 

Harry M. Zweig Memorial Fund for Equine Research

Publications Resulting from Zweig Funding 1990-2012

1990

  1.   Invasive equine tropho-blast expresses conventional class I Major Histocompatibility Complex antigens.
    Donaldson WL, Zhang CH, Oriol JG, Antczak DF. 1990. Development . 110:63-71. This paper was awarded one of two national Phi Zeta prizes for papers submitted by post-graduate veterinary students in 1991.
  2. Xenogeneic donkey-in-horse pregnancy created by embryo transfer: immunological aspects of a model of early abortion.
    Allen WR, Kydd J, Antczak DF. 1990. Chapter 22 Immunology of the Fetus (G. Chaouat, ed.), CRC Press, Boca Raton, FL. pp 267-292.

1991

  1. Analysis of horse and donkey gonadotrophin genes using Southern blotting and DNA hybridization techniques.
    Stewart F, Maher J. 1991. J. Reprod. Fertil. Suppl.. 44:19-25. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  2. Characterization of BPV-like DNA in Equine Sarcoids.
    Angelos JA, Marti E, Lazary S, Carmichael LE. 1991. Archives of Virology. 119:95-109. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  3. Molecules of the early equine trophoblast.
    Oriol JG, Donaldson WL, Dougherty DA, Antczak DF. 1991. J. Reprod. Fert. Suppl.. 44:455-462.

1992

  1. Developmental regulation of class I Major Histocompatibility Complex antigen expression by equine trophoblastic cells.
    Donaldson WL, Oriol JG, Plavin A, Antczak DF. 1992. Differentiation. 52:69-78.
  2. Differentiation of chronic lymphocytic leukemia in the horse: a report of two cases.
    Dascanio JJ, Zhang CH, Antczak DF, Blue JT, Simmons TR. 1992. J Vet Internal Med. 6:225-229.
  3. Molecular cloning of equine CD44 cDNA by a COS cell expression system.
    Tavernor AS, Deverson EV, Coadwell WJ, Lunn DP, Zhang C, Davis W, Butcher GW. 1992. Immunogenetics. 37:474-477. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  4. Selective IgM deficiency and abnormal B-cell response in a foal.
    Weldon AD, Zhang CH, Antczak DF, Rebhun WC. 1992. J Am Vet Med Assoc. 201:1396-1398.
  5. The Major Histocompatibility Complex of the Horse.
    Antczak DF. 1992. Equine Infectious Diseases VI, Proceedings of the Sixth International Conference, 7th-11th July, 1991, Cambridge UK (Plowright W, Rossdale PD, Wade JF, eds.), R&W Publications (Newmarket) Ltd. p. 99-112.
  6. Unusual selective immunoglobulin deficiency in an Arabian foal.
    Boy M, Zhang CH, Antczak DF, Hamir A, Whitlock R. 1992. J Vet Internal Med. 6:201-205.
  7. Water and salt balance in exercising horses.
    Kleps, NA, Houpt, KA, Calabria-Maher, V. 1992. The Equine Athlete. 5:5-11.

1994

  1. An equine B cell surface antigen defined by a monoclonal antibody..
    Zhang CH, Donaldson WL, Antczak DF. 1994. Vet Immunol Immunopathol. 42:91-102.
  2. Down-regulation followed by re-expression of equine CD4 molecules in response to phorbol myristate acetate.
    Zhang CH, Grünig G, Davis W, Antczak DF. 1994. Vet Immunol Immunopathol. 42:71-82.
  3. Horse cDNA clones encoding two MHC class I genes.
    Barbis DP, Maher JK, Stanek J, Klaunberg BA, Antczak DF. 1994. Immunogenetics. 40: 163.
  4. Intravascular leukostasis and systemic aspergillosis in a horse with acute subleukemic myelomonocytic leukemia.
    Buechner-Maxwell V, Zhang C, Robertson J, Jain NC, Antczak DF, Feldman BF, Murray MJ. 1994. J Vet Int Med. 8:258-263.
  5. MHC gene expression in placentas of domestic animals.
    Antczak DF, Maher JK, Grünig G, Donaldson WL , Kydd J, Allen WR. 1994. SERONO Symposium: Immunobiology of Reproduction (J.S. Hunt, ed.). pp. 153-169.
  6. Molecular cloning and characterization of horse DQA cDNA.
    Szalai G, Antczak DF, Gerber H, Lazary S. 1994. Immunogenetics. 40:457.
  7. Molecular cloning and characterization of horse DQB cDNA.
    Szalai G, Antczak DF, Gerber H, Lazary S. 1994. Immunogenetics. 40:458.
  8. Paternal and maternal Major Histocompatibility Complex class I antigens are expressed co-dominantly by equine trophoblast.
    Donaldson WL, Oriol JG, Pelkaus CL, Antczak DF. 1994. Placenta. 15:123-135.
  9. Variation in expression of MHC class II antigens on horse lymphocytes determined by MHC haplotype.
    Barbis DP, Bainbridge D, Crump AL, Zhang CH, Antczak DF. 1994. Vet Immunol Immunopathol. 42:103-114.

1995

  1. The complete cDNA and deduced amino acid sequence of equine IgE. Navarro P, Barbis DP, Antczak D, Butler JE. 1995. Molec Immunol. 32:1-8.

1996

  1. Summary Report of the Second Equine Leucocyte Antigen Workshop. Lunn DP, Holmes MA, Antczak DF. 1996. Vet Immunol Immunopathol. 54:159-161.

1997

  1. Mitogenesis and Chondrocytic Differentiation of Mesenchymal Cells Exposed to Transforming Growth Factor-B.
    Wooster AA, Nixon AJ, Fortier LA, Toland B, Williams J. 1997. Vet Surg. 26:434-435.

1998

  1. Disparate Chondrocyte Metabolism in Three-Dimensional Fibrin Cultures Derived from Autogenous or Commercially Manufactored Fibrinogen. Fortier LA, Brofman PJ, Nixon AJ, Mohammed HO. 1998. Am J Vet Res. 59:514-520.
  2. Isolation and Chondrocytic Differentiation of Equine Bone-Marrow-Derived Mesenchymal Stem Cells.
    Fortier LA, Nixon AJ, Williams J, Cable CS. 1998. Am J Vet Res. 59:1182-1187.
  3. Outcome of horses diagnosed with and treated for heaves (abstract). Ainsworth DM, Eicker SW. 1998. Proc World Equine Airways Symp. 1:17.
  4. Report of the Second Equine Leucocyte Antigen Workshop, Squaw Valley, California, July 1995. Lunn DP, Holmes MA, Antczak DF, et al.. 1998. Vet Immunol Immunopath. 62:101-143.
  5. The equine homologue of LFA-1 (CD 11a/CD18): cellular distribution and differential determinants. Zhang CH, Davis WC, Grünig G, Antczak DF. 1998. Vet Immunol Immunopath. 62:167-183.
  6. Use of IGF-I somatic gene therapy in the treatment of osteoarthritis. Nixon AJ, Brower-Toland BD, Robbins P, Evans CH. 1998. Proc, International Meeting, Gene Therapy Approaches to Arthritic and Allied Conditions. NIH. p 17.

1999

  1. Effects of extrathoracic airway obstruction on intrathoracic pressure and pulmonary artery pressure in exercising horses.
    Hackett RP, Ducharme NG, Ainsworth DM, Erickson BK, Erb HN, Soderholm LV Jr, Thorson LM. 1999. Am J Vet Res. 60(4):485-94.
  2. Equine dinucleotide repeat loci COR001-COR020.
    Hopman TJ, Han EB, Story MR, Schug MD, Aquadro C, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet. 30(3):225-6.
  3. Equine dinucleotide repeat loci COR021-COR040.
    Murphie AM, Hopman TJ, Schug, MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30(3):235.
  4. Equine dinucleotide repeat loci COR041-COR060.
    Ruth LS, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Animal Genetics. 30:320.
  5. Equine dinucleotide repeat loci COR061-COR080.
    Tallmadge R, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30:462-463.
  6. Equine dinucleotide repeat loci COR081-COR100.
    Tallmadge R, Evans KG, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30(6):462-78.
  7. Genome methylation in interspecific eutherian hybrids.
    Römer I, Grützner F, Winking H, Haaf T, Niveleau A, Orth A, Skidmore L, Antczak D, Fundele R. 1999. Nature. 401:131-132.
  8. Report of the International Equine Gene Mapping Workshop: Male Linkage Map. Guérin G, Bailey E, Bernoco D, Anderson I, Antczak DF, et al. 1999. Anim. Genet.. 30:341-354.
  9. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface protein A (OspA) in horses.
    Chang Y-F, Novosol V, McDonough SP, Jacobsen RJ, Chang C-F, Divers T, Quimby FW, Shin S, Lein DH. 1999. Vaccine. 18:540-548.

2000

  1. An in vitro comparison of cordopexy, cordopexy and laryngoplasty, and laryngopolasty for treatment of equine laryngeal hemiplegia. Jansson N, Ducharme NG, Hackett RP, Mohammed HO. 2000. Veterinary Surgery. 29(4):326-334.
  2. Articular IGF-I therapy via adenoviral recruitment of the synovial lining. Bent SJ, Saxer RA, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2000. Trans, 46th Annual Meeting, Orthopaedic Research Society. 25:230.
  3. Cartilage repair using genetically modified chondrocytes secreting increased IGF-I ligand levels. Nixon AJ, Brower-Toland BD, Saxer RA, Goodrich LR, Robbins PD, Evans CH. 2000. Vet Surg. 29:471.
  4. Delivery of biologically effective steady-state concentrations of IGF-I to cultured chondrocytes by adenoviral gene therapy.
    Brower-Toland BD, Saxer RA, Robbins PD, Evans CH, Nixon AJ. 2000. Trans, 46th Annual Meeting, Orthopaedic Research Society. 25:1064.
  5. Direct adenovirus-mediated IGF-I gene transfer enhances transplant chondrocyte function. Nixon AJ, Brower-Toland BD, Robbins PD, Evans CH. 2000. Proceedings, International Cartilage Repair Society, 3rd International Symposium. p20.
  6. Effects of pulmonary abscesses on racing performance of horses treated at referral veterinary medical teaching hospitals: 45 cases (1985-1997). Ainsworth DM, Erb HN, Eicker SW, Yeager AE, Viel L, Sweeney CR, Lavoie JP. 2000. JAVMA. 216(8):1282-1287.
  7. Elevated synovial IGF-I following adenoviral IGF-I transgene delivery for equine joint disease. Goodrich LR, Nixon AJ, Brower-Toland BD, Bent SJ, Robbins PD, Evans CH. 2000. Vet Surg. 29:463.
  8. Enhanced articular cartilage repair in the horse using chondrocytes transduced with an adenovirus-BMP7 transgene.
    Goodrich LR, Nixon AJ, Hidaka C, Quitoriano M, Brower-Toland BD, Bent SJ, Warren RG, Crystal RG. 2000. Vet Surg. 29:463.
  9. Enhanced healing of articular cartilage defects with genetically engineered chondrocytes expressing bone morphogenetic protein-7. Hidaka C, Goodrich LR, Quitoriano M, Brower-Toland BD, Bent SJ, McCarthy D, Attia E, Warren RF, Crystal RG, Nixon AJ. 2000. Japanese Society of Clinical Biomechanics. Annual Meeting.
  10. Equine trophoblast as an immunological target.
    Baker JM, Bamford AI, Carlson ML, McCullough CE, Antczak DF. 2000. Journal of Reproduction and Fertility. (Suppl 56:635-644.
  11. Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks. Chang Y-F, Novosol V, McDonough SP, Chang C-F, Jacobsen RJ , Divers T, Quimby FW, Shin S, Lei DH. 2000. Vet Pathol. 37:68-76.
  12. First comprehensive low-density horse linkage map based on two 3-generation, full-sibling, cross-bred horse reference families. Swinburne J, Gerstenberg C, Breen M, Aldridge V, Lockhart L, Marti E, Antczak D, Eggleston-Stott M, Bailey E, Michelson J, Røed K, Lindgren G, von Haeringen W, Guérin G, Bjarnason J, Allen T, Binns M. 2000. Genomics . 66:123-134.
  13. Growth factor gene induced cartilage repair.
    Nixon AJ, Bent SJ, Saxer RA, Brower-Toland BD, Evans CH. 2000. Proceedings, International Cartilage Repair Society, 3rd International Symposium. May.
  14. Human granulocytic ehrlichiosis agent (HGE) infection in a pony vaccinated with recombinant OspA vaccine and challenged by exposure to naturally infected ticks. Chang Y-F, McDonough SP, Shin K-S, Chang C-F, Divers T. 2000. Clin Diagn Immunol. 7:68-71.
  15. Immunogenetics of the horse.
    Bailey E, Marti E, Fraser DG, Antczak DF, Lazary S. 2000. Chapter 7, The Genetics of the Horse (A.T. Bowling and A. Ruvinsky, eds.), CAB International, Oxon, U.K., pp. 123-155.
  16. Insulin-like growth factor-I gene therapy applications in cartilage repair and degenerative joint diseases. Nixon AJ, Brower-Toland BD, Bent SJ, Saxer RA, Wilke MJ, Robbins PD, Evans CH. 2000. Clin Orthop Related Res. 379S:S201-S213.
  17. Polysaccharide storage myopathy in Morgan, Arabian, and Standardbred related horses and Welsh-cross ponies.
    Valentine BA, McDonough SP, Chang Y-F, Vonderchek AJ. 2000. Vet Pathol. 37:193-196.
  18. Reproduction and modern breeding technologies in the mare.
    Allen WR and Antczak DF. 2000. Chapter 12, The Genetics of the Horse (A.T. Bowling and A. Ruvinsky, eds.), CAB International, Oxon, U.K.. pp. 307-341.
  19. The potential for acquired long QT syndrome (LQTS) in horses. Finley MR, Lillich J, Mitchell KE, Freeman LC, Gilmour RF. 2000. J Veterinary Internal Medicine. 14:355. Abstract
  20. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang YF, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers TJ, Quimby FW, Shin S, Lein DH. 2000. Vaccine. 18(5-6):540-548.

2001

  1. Accelerated cartilage defect healing in horses by implantation of genetically modified chondrocytes expressing bone morphogenetic protein-7. Hidaka C, Goodrich LR, Quitoriano M, Bent SJ, Brower-Toland BD, Crystal RG, Nixon AJ. 2001. Trans, 47th Annual Meeting, Orthopaedic Research Society. 26:157.
  2. Cartilage repair using genetically modified chondrocytes secreting increased IGF-I ligand levels.
    Nixon AJ, Brower-Toland BD, Robbins PD, Evans CH. 2001. Molecular Therapy. 3:S284.
  3. Direct adenovirus-mediated insulin-like growth factor-I gene transfer enhances transplant chondrocyte function.
    Brower-Toland BD, Saxer RA, Goodrich LR, Mi Z, Robbins PD, Evans CH, Nixon AJ. 2001. Human Gene Therapy. 12:117-129
  4. Direct in vivo adenoviral IGF-I transgene injection results in significant elevations of synovial IGF-I. Goodrich LR, Bent SJ, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2001. Trans, 47th Annual Meeting, Orthopaedic Research Society. 26:283.
  5. Gene mediated control of cartilage degradation by combination IGF-I/IL-1 receptor antagonist therapy.
    Nixon AJ, Haupt JL, Frisbie DD, Morisett SS, Robbins PD, Ghivizzani S, Evans CH, McIlwraith CW. 2001. Vet Surg. 30:294.
  6. Gene mediated insulin-like growth factor-I delivery to the synovium. Saxer RA, Bent SJ, Brower-Toland BD, Mi Z, Robbins PD, Evans CH, Nixon AJ. 2001. J Orthop Res. 19(5):759-67.
  7. Insulin-Like Growth Factor-I Gene Expression Patterns During spontaneous Repair of Acute Articular Cartilage Injury.
    Fortier LA, Balkman CE, Sandell LJ, Radcliffe A, Nixon AJ. 2001. J Orthop Res. 19:720-728.
  8. Intraarticular injection of adenoviral IGF-I transgene results in significant elevations of synovial IGF-I. Goodrich LR, Bent SJ, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2001. Molecular Therapy. 3:S390.
  9. Lyme disease in horses. Divers TJ, Chang YF, Jacobson RH, McDonough SP. 2001. Compendium on Continuing Education for the Practicing Veterinarian. 23(4):375-381.
  10. Outcome of horses diagnosed with and treated for heaves (recurrent airway obstruction). Aviza GA, Ainsworth DM, Eicker SW, Santiago MA, Divers TJ, Perkins GA. 2001. Equine Veterinary Education. 13(5):243-246.
  11. PCR-based genotyping for the equine MHC class II locus DBQ—multiple alleles or multiple loci? Bird H, Savidge C, Miller DC, Hopman T, Antczak DF. 2001. Plant and Animal Genome IX Conference, San Diego, Jan. 13-17. Abstract
  12. The gene jockeys of the horse genome project.
    Antczak DF. 2001. Proc. 19th Annual ACVIM Forum, Denver, CO. pp. 257-259.
  13. They're off and running—applications of equine genetic research. Antczak DF. 2001. Proc. 19th Annual ACVIM Forum, Denver, CO. pp. 260-262.

2002

  1. Cloning and Molecular Characterization of an Immunogenic LigA Protein of Leptospira interrogans. Palaniappan RUM, Chang YF, Jusuf SSD, Artiushin S, Timoney JF, McDonough SP, Barr SC, Divers TJ, Simpson KW, McDonough PL, Mohammed HO. 2002. Infection and Immunity. 70(11):5924-5930.
  2. Expression and co-association of ERG1, KCNQ1 and KCNE1 potassium channel proteins in horse heart.
    Finley MR, Lillich J, Li Y, Mitchell KE, Hua F, Gilmour RF, Freeman LC. 2002. Am J Physiol Heart Circ Physiol. 283(1):H126-38.
  3. Formation and dissolution of the mare-foal bond. Houpt, KA. 2002. Applied Animal Behavior Science. 78:319-328.
  4. IgG antibody responses to an inhaled antigen in horses with "heaves" (recurrent airway obstruction).
    Ainsworth DM, Appleton JA, Antczak DF, Santiago MA, Aviza G. 2002. Vet Immunol Immunopathol. Jan 15;84(3-4):169-80.
  5. Insulin-Like Growth Factor-I Enhances Cell-Based Repair of Articular Cartilage. Fortier LA, Mohammed HO, Lust G, Nixon AJ. 2002. J Bone Joint Surg Br. 84:276-288.
  6. Leukocytes trapped in the fetal membranes of newborn foals.
    Volkmann DH, Gilbert RO, Gradil C, and Linke R. 2002. Proceedings of the 8th International Symposium on Equine Reproduction. Published as Evans MJ (Ed), Equine Reproduction VII. Special Issue Theriogenology:787-790.
  7. Phenotypic Expression of Equine Articular Chondrocytes Grown in Three-Dimensional Cultures Supplemented with Suprapphysiologic Concentrations of Insulin-Like Growth Factor-I.
    Fortier LA, Nixon AJ, Lust G. 2002. Am J Vet Res. 63:301-305.
  8. Sound signature for identification and quantification of upper airway disease in horses. Cable CS, Ducharme NG, Hackett RP, Erb HN, Mitchell LM, Soderholm VL. 2002. AJVR. 63:12.

2003

  1. Additional intraarticular therapies. Fortier, Lisa A. 2003. Chapter 10.16, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 555-557.
  2. Advances in equine immunology: Havemeyer workshop reports from Santa Fe, New Mexico, and Hortobagy, Hungary.
    Marti E, Horohov DW, Antczak DF, Lazary S, Lunn DP. 2003. Veterinary Immunology and Immunopathology. 91(3-4):233-243
  3. An Ordered BAC contig map of the equine Major Histocompatibility Complex. Gustafson AL, Tallmadge RL, Ramlachan N, Miller D, Bird H, Antczak DF, Raudsepp T, Chowdhary BP, Skow LC. 2003. Cytogenet Genome Res. 102:189-195.
  4. Arthroscopic surgery of the carpal and digital tendon sheaths. Nixon, Alan J. 2003. Clinical Techniques in Equine Practice. 1(4):245-256.
  5. Arthroscopic techniques for cartilage repair. Nixon, Alan J. 2003. Clinical Techniques in Equine Practice. 1(4):257-269.
  6. Characterization of the b-2-microglobulin gene of the horse.
    Tallmadge RL, Lear TL, Johnson AK, Guerin G, Millon LV, Carpenter SL,Antczak DF. 2003. Immunogenetics. 54:725-733.
  7. Characterization of the horse (Equus caballus) IGHA gene.
    Wagner B, Greiser-Wilke I, Antczak DF. 2003. Immunogenetics. 55:552-560.
  8. Complementary therapies for the treatment of musculoskeletal disorders. Haussler, Kevin K. 2003. Chapter 10.19, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 567-571.
  9. Cytokine profiles and long-term visur-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D. Zhang Y, Smith PM, Frampton AR, Osterrieder N, Jennings SR, O'Callaghan DJ. 2003. Viral Immunology. 16(3):307-320.
  10. Do thoroughbred and standardbred horses have similar increases in pulmonary vascular pressures during exertion?.
    Hackett RP, Ducharme NG, Gleed RD, Mitchell L, Soderholm LV, Erickson BK, Erb HN. 2003. Canadian Journal of Veterinary Research. 67(4):291-296.
  11. Equine Gene Mapping Workshop.
    Antczak, Douglas F. 2003. Havemeyer Foundation, August 2003, Kruger Park, South Africa.
  12. Generation and characterization of an EICPO null mutant of equine herpesvirus 1. Yao H, Osterrieder N, O'Callaghan DJ. 2003. Virus Research. 98(2):163-172.
  13. Genomic Applications to Equine Immunity (Booklet).
    Antczak, Douglas F. 2003. Havemeyer Foundation Workshop, June 2003, Ithaca, NY.
  14. Immunomodulators in respiratory disease treatment.
    Flaminio, MJBF. 2003. Chapter 8.11, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 445-449.
  15. Investigations into the role of the thyrohyoid muscles in the pathogenesis of dorsal displacement of the soft palate in horses.
    Ducharme NG, Hackett RP, Woodie JB, Dykes N, Erb HN. 2003. Equine Veterinary Journal. 35(3):258-263.
  16. Lyme disease. Divers, Thomas J. 2003. Chapter 2.7, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 54-56.
  17. Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE. Wagner B, Radbruch A, Rohwer J, Leibold W. 2003. Veterinary Immunology and Immunopathology. 92(1-2):45-60.
  18. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes. Takahashi T, Yawata M, Raudsepp T, Lear TL, Chowdhary BP, Antczak DF, Kasahara M. 2003. Eur J Immunol. 34:773-784.
  19. Prevention and treatment of thrombosis, phlebitis, and laminitis in horses with gastrointestinal diseases.
    Divers TJ. 2003. Veterinary Clinics of North America: Equine Practice. 19(3):779-790.
  20. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Ainsworth DM, Grunig G, Matychak MB, Young J, Wagner B, Erb HN, Antczak DF. 2003. Veterinary Immunology and Immunopathology. 96(1-2):83-91.
  21. Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions. Perkins GA, Nydam DV, Flaminio MJBF, Ainsworth DM. 2003. Journal of Veterinary Internal Medicine. 17(3):337-342.
  22. Spinal coard diseases causing paresis and atrophy in the limbs. Divers, Thomas J. 2003. Chapter 14.4, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 750-753.
  23. Structural and functional basis for the long QT syndrome: relevance to veterinary patients. Finley M, Lillich J, Gilmour RF Jr., Freeman LC. 2003. Journal of Veterinary Internal Medicine. 17:473-488.
  24. The effect of strenuous exercise on mRNA concentrations of interleukin-12, interferon-gamma and interleukin-4 in equine pulmonary and peripheral blood mononuclear cells.
    Ainsworth DM, Appleton JA, Eicker SW, Luce R, Flaminio MJ, Antczak DF. 2003. Vet Immunol Immunopath. 91:61-71.
  25. The first generation whole genome radiation hybrid map in the horse identifies conserved segments in human and mouse genomes. Chowdhary BP, Raudsepp T, Sata SR, Goh G, Millon LV, Alan V, Piumi F, Guerin G, Swinburne J, Binns M, Michelson J, Murray J, Antczak DF, Womack JE, Skow LC. 2003. Genome Research. 13:742-751.
  26. The second generation of the International Equine Gene Mapping Workshop half-sibling linkage map. Guerin G, Bailey E, Bernoco D, Anderson I, Antczak DF, Bell K, Biros I, Bjornstad G, Bowlilng AT, Brandon R, Caetano AR, Cholewinski G, Colling D, Eggleston M, Ellis N, Flynn J, Gralak B, Hasegawa T, Ketchum M, Lindgren G, Lyons LA, Millon LV, Mariat D, Murray J, Neau A, Loed K, Sandberg K, Skow LC, Tammen I, Tozaki T, Van Dyk E, Weiss B, Young A, Ziegle J. 2003. Animal Genetics. 34(3):161-168.
  27. Thoracolumbar spinal cord disorders causing upper motor neuron signs in the hindlimbs. Perkins GA, Divers TJ. 2003. Chapter 14.5, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 753-755.
  28. Urinary and hepatic disorders in neonatal foals.
    Divers, TJ, Perkins, G. 2003. Clinical Techniques in Equine Practice. 2(1):67-78.

2004

  1. Arthroscopic reattachment of osteochondritis dissecans lesions using resorbable polydioxanone pins.
    Nixon AJ, Fortier LA, Goodrich LR, Ducharme NG. 2004. Equine Veterinary Journal. 36(5):376-383.
  2. Complication of partial stylohyoidectomy for treatment of temporohyoid osteoarthropathy and an alternative surgical technique in three cases. Pease AP, van Biervliet J, Dykes NL, Divers TJ, Ducharme NG. 2004. Equine Veterinary Journal. 36(6):546-550.
  3. Development and validation of a periarticular injection technique of the sacroilliac joint in horses. Engeli E, Haussler KK, Erb HN. 2004. Equine Veterinary Journal. 36(4):324-330.
  4. Equine herpesvirus type 1 (EHV-1) glycoprotein K is required for efficient cell-to-cell spread and virus egress. Neubauer A, Osterrieder N. 2004. Virology. 329(1):18-32.
  5. Evaluation of decision criteria for detection of spinal cord compression based on cervical myelography in horses: 38 cases (1981-2001). van Biervliet J, Scrivani PV, Divers TJ, Erb HN, deLahunta A, Nixon AJ. 2004. Equine Veterinary Journal. 36(1):14-20.
  6. Exostoses of the caudal perimeter of the radial physis as a cause of carpal synovial sheath tenosynovitis and lameness in horses: 10 cases (1999-2003). Nixon AJ, Schachter BL, Pool RR. 2004. Journal of the American Veterinary Medical Association. 224(2):264-270.
  7. Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis. Semevolos SA, Nixon AJ, Strassheim ML. 2004. American Journal of Veterinary Research. 65(1):110-115.
  8. Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA. Palaniappan RU, Chang YF, Hassan F, McDonough SP, Pough M, Barr SC, Simpson KW, Mohammed HO, Shin S, McDonough P, Zuerner RL, Au J, Roe B. 2004. J Med Microbiology. 53(Pt 10):975-984.
  9. Extradural undifferentiated sarcoma causing spinal cord compression in 2 horses. van Biervliet J, Alcaraz A, Jackson CA, Njaa B, deLahunta A, Divers TJ. 2004. Journal of Veterinary Medicine. 18(2):248-251.
  10. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E. Frampton Ar Jr, Smith PM, Zhang Y, Grafton WD, Matsumura T, Osterrieder N, O'Callaghan DJ. 2004. Virus Genes. 29(1):9-17.
  11. Radiographic and pathologic characterization of lateral palmar intercarpal ligament avulsion fractures in the horse.
    Beinlich CP, Nixon AJ. 2004. Veterinary Radiology and Ultrasound. 45(6):532-537.
  12. The complete map of the Ig heavy chain constant gene region reveals evidence for seven IgG Isotypes and for IgD in the horse. Wagner B, Miller DC, Lear TL, Antczak DF. 2004. J Immunol. 173:230-3242.
  13. The proliferation inhibitory proteins p27(Kip1) and retinoblastoma involved in the control of equine lymphocyte proliferation. Flaminio MJBF, Yen A, Antczak DF. 2004. Veterinary Immunology and Immunopathology. 102(4):363-377.
  14. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain Kya is not functionally equivalent to full-length pg2 encoded by EHV-1 wild-type strainRacL11. von Elinem J, Wellington J, Whalley JM, Osterrieder K, O'Callaghan DJ, Osterrieder N. 2004. Journal of Virology. 78(6):3003-3013.

2005

  1. Age-related changes in serum insulin-like growth factor-I, insulin-like growth factor-I binging protein-3 and articular cartilage structure in Thoroughbred horses. Fortier LA, Kornatowski MA, Mohammed HO, Jordan MT, O'Cain LC, Stevens WB. 2005. Equine Veterinary Journal. 37(1):37-42.
  2. Antibiotic treatment of experimentally Borrelia burgforferi-infected ponies. Chang YF, Ku YW, Chang CF, Chang CD, McDonough SP, Divers T, Pough M, Torres A. 2005. Veterinary Microbiology. 107:285-294.
  3. Can an external device prevent dorsal displacement of the soft palate during strenuous exercise? Woodie JB, Ducharme NG, Hackett RP, Erb HN, Mitchell LM, Soderholm LV. 2005. Equine Vet J. 7(4):355-359.
  4. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. Frampton Ar Jr, Goins WF, Cohen JB, von Einen J, Osterrieder N, O'Callaghan DJ, Glorioso JC. 2005. Journal of Virology. 79(5):3169-73.
  5. Evaluation of lig-based conventional and real time PCR for the detection of Pathogenic leptospires. Palaniappan RU, Chang YF, Chang CF, Pan MJ, Yang CW, Harpending P, McDonough SP, Dubovi E, Divers T, Qu J, Roe B. 2005. Mol Cell Probes. 19(2):111-117.
  6. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1)completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice. Smith PM, Sahan SM, Rorex CB, von Einen J, Osterrieder N, O'Callaghan DJ. 2005. Journal of Virology. 79(8):5105-15.
  7. Horse cytokine/IgG1 fusion proteins mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF. 2005. Vet. Immunol. Immunopathol. 105:1-14.
  8. Inhibition of lymphocyte proliferation and activation: a mechanism used by equine invasive trophoblast to escape the maternal immune response. Flaminio MJBF, Antczak DF. 2005. Placenta. 26(2-3):148-159.
  9. Potential of equine herpesvirus 1 as a vector for immunization. Trapp S, von Einem J, Hoffmann H, Kostler J, Wild J, Wagner R, Beer M, Osterrieder N. 2005. Journal of Virology. 79(9):5445-54.
  10. Stem Cells: Classifications, Controversies and Clinical Applications. Fortier LA. 2005. Vet Surg. 34:415-423.
  11. The use of hormone profiles in the study of the pathogenesis of the mare Reproductive Loss Syndrome.
    Volkmann DH, Zent W, Riddle WT, Little TV, Durenberger J, Potenze K, Sibley L, Roser JF. 2005. Theriogenology. Submitted.

2006

  1. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.
    Kim D, Kordick D, Divers T, Chang YF. 2006. J Vet Sci. 7(4):355-359.
  2. A monoclonal antibody to equine interleukin 4.
    Wagner B, Hillegas JM, Antczak DF. 2006. Vet. Immunol. Immunopathol. 110:363-367.
  3. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MF, Sussman KH, Metzger SM, Holland R, Osterrieder N. 2006. Vaccine. In press.
  4. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KL, Metzgar SM, Holland R, Osterrieder N. 2006. Vaccine. Apr 24; 24(17):363-45.
  5. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? Ross CT, Goodman LB, von Einem J, Osterrieder N. 2006. Expert Rev Vaccines. Feb; 5(1):119-31.
  6. IgE and IgG antibodies in skin allergy of the horse.
    Wagner B, Miller WH, Morgan EE, Hillegas JM, Erb HN, Leibold W, Antczak DF. 2006. Vet. Res. 37:813-825.
  7. Immunoprotection of recombinant leptospiral immunoglobulin like A protein (LigA) against Leptospira interrogans serovar Pomona infection. Raghavan PUM, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF. 2006. Infectious Immunology. 74:1745-1750.
  8. Marek's disease virus: from miasma to model.
    Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. 2006. Nat Rev Microbiol. Apr;4(4):283-94.
  9. Modified live vaccines against infections with equine herpesvirus type 1 (EHV-1) - Quo vaditis? Rosas C, Goodman LB, von Einem J, Osterrieder N. 2006. Expert Review of Vaccines. 5(1):119-31.
  10. Occurrence of IgE in foals: evidence of transfer of maternal IgE by the colostrum and late onset of endogenous IgE production in the horse. Wagner B, Flaminio JBF, Hillegas J, Leibold W, Erb HN, Antczak DF. 2006. Vet. Immunol. Immunopathol. 110:269-278.
  11. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. Slater JD, Lunn DP, Horohov DW, Antczak DF, Babiuk L, Breathnach C, Chang YW, Davis-Poynter N, Edington N, Ellis S, Foote C, Goehring L, Kohn CW, Kydd J, Matsumura T, Minke J, Morley P, Mumford J, Neubauer T, O'Callaghan D, Osterrieder K, Reed S, Smith K, Townsend H, van der Meulen K, Whalley M, Wilson WD. 2006. Vet. Immunol Immunopathol. 2006 May 15; 111(1-2);3-13.
  12. The a-TIF (VP16) homologue (ETIF) of equine herpesvirus type 1 (EHV-1) is essential for secondary envelopment and virus egress. von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. 2006. Journal of Virology. 80(6) In Press.

  13. The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress.
    von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. 2006. J Virol. Mar; 80(6):2609-20.
  14. Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli.
    Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. BioTechniques. 40(2):191-197.
  15. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.
    Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Biotechniques. Feb; 40(2):191-7.

2007

  1. A domain of the Leptospira LigB contributes to high affinity binding of fibronectin. Lin YP,Chang YF. 2007. Biochemical and Biophysical Research Communications. 362:443-448.
  2. Cyclooxygenase-2 immunoreactivity in equine ocular squamous cell carcinoma. Rassnick KM, Njaa BL. 2007. J Vet Diag Investigation. 19(4): in press.
  3. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Faisal SM, Yan W, Chen CS, Palaniappan RUM, He H, McDonough SP, Chang YF. 2007. Vaccine. 26:277-287.
  4. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model.
    Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ. 2007. The Journal of Bone and Joint Surgery. 89-B(5):672-685.
  5. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF, Chen CS, Palaniappan RUM, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF. 2007. Vaccine. 25:8190-8197.
  6. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). von Einem J, Smith PM, Van de Walle GR, O'callaghan DJ, Osterrieder N. 2007. Virology. January 22; [Epub ahead of print].
  7. Leptospirosis: pathogenesis, immunity, and diagnosis.
    Palaniappan RUM, Ramanujam S, Chang YF. 2007. Current Opinion in Infectious Diseases. 20:284-292.
  8. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). Ross CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N. 2007. Virus. January 20; [Epub ahead of print].
  9. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons.
    Schnabel LV, Mohammed HO, Miller BJ, McDermot WG, Jacobson MS, Santangelo KS, Fortier LA. 2007. J Ortho Research. 25:230-240.
  10. The effect of CpG-ODN on antigen presenting cells of the foal. Flaminio MJBF, Borges AS, Nydam DV, Horohov DW, Hecker R, Matychak MB. 2007. Journal of Immune Based Therapies and Vaccines. 5:1-17.
  11. The effect of CpG-ODN on antigen presenting cells of the foal. Flaminio MJBF, Borges AS, Nydam DV, Horohov DW, Hecker R, Mattychak MB. 2007. Journal of Immune Based Therapies and Vaccines. 1:1-17.

2008

  1. A defined medium supports changes consistent.
    J, McPartlin LA, Littell J, Mark E, Nelson JL, Travis AJ. 2008. 15;69(5):639-50. Epub.
  2. Alphaherpesviruses and Chemokines: pas de deux not yet brought to perfection. Van de Walle, GR, Jarosinski, KW. 2008. J. Virol. 82,6090-6092.
  3. Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine .... Van de Walle, GR, Kaufer BB, Chbab N. 2008. J Biol Chem. [Epub ahead of print.
  4. Calcium binds to leptospiral immunoglobulin-like protein, LigB and modulates fibronectin-binding.. Lin, Y.P., Raman, R., Sharma, Y., and Chang, Y.F. 2008. J. Biol. Chem. 283:25140-25149.
  5. Detection of Equine Herpesvirus-1 in Nasal Swabs of Horses by Quantitative Real-Time PCR. Perkins GA, Goodman LB, Dubovi EJ, Kim SG. 2008. Journal of Veterinary Internal Medicine. 08.95 [Epub ahead of print]
  6. Equine Herpesvirus Type 1 (EHV-1) based experimental vaccine. Rosas, C.T., Paessler, S, Ni, H.. 2008. Am J Trop Med Hyg. 8, 83-92.
  7. Equine herpesvirus type 1 (EHV-1) entry via endocytosis is facilitated by aV .... Van de Walle, ED, Peters GR, Van der Ven BC, O'Callaghan, DJ N.. 2008. J Virol. [Epub ahead of print].
  8. Foal Monocyte-Derived Dendritic Cells Become Activated Upon Rhodoccoccus equi Infection... Nydam DV, Marquis H, Matychak, MB, Giguere S.. 2008. 16(2):176-83-Epub.
  9. Image-guided Tissue Engineering of Anatomically Shaped Implants via MRI and Micro-CT ... Ballyns, J, Gleghorn J, Niebrzydowski V, Potter, H, Maher S, Wright T, Bonassar L.. 2008. Tissue Engineering Part A.. 14(7):1195-1202.
  10. Monoclonal antibodies to equine interferon-a (IFN-a ): New tools to neutralize IFN-activity .... Hillegas M, Flaminio J, Wattrang E.. 2008. Epub. 15;125(3-4):315-25.
  11. The C-Terminal Variable Domain of LigB from Leptospira Mediates Binding to Fibronectin. Lin YP, Chang YF. 2008. J. Vet. Sci. 9(2), 133-144.
  12. Varicellovirus UL 49.5 Proteins Differentially affect the Function of the Transporter .... Koppers-Lalic D, Verweij MC, Lipiska AD, Wang Y, . 2008. t PloS Pathogens. 05/30;4(5):e1000080.

2009

  1. A point mutation in a herpesvirus polymerase determines neuropathogenicity. Goodman LB, Perkins GA, Buckles EL, Osterrieder N. 2009. Journal of Infectious Diseases. in press.
  2. A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease..
    Van de Walle GR, Goupil R, Wishon C, Damiani A, Perkins GA, Osterrieder N.. 2009. Journal of Infectious Diseases. in press.
  3. Effective treatment of respiratory alphaherpesvirus infection using RNA interference. Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, Brosnahan M, Buckles EL, Osterrieder N, Van de Walle GR.. 2009. Journal of Infectious Diseases. in press.
  4. Equine bronchial epithelial cells differentiate into ciliated and mucus producing cells in vitro. Schwab UE, Fulcher ML, Randell SH, Russell DG.. 2009. In Vitro Cell Dev Biol Anim. Nov 14.
  5. Ex vivo generation of mature equine monocyte-derived dendritic cells. Cavatorta DJ, Erb HN.. 2009.
  6. Expression of essential B cell genes and immunoglobulin isotypes suggests active development and gene recombination during equine gestation. Tallmadge RL, McLaughlin K, Secor E, Ruano D, Matychak MB.. 2009.
  7. Image-guided tissue engineering of anatomically shaped implants via MRI and micro-CT using injection molding.
    Ballyns J, Gleghorn J, Niebrzydowski V, Potter H, Maher S, Wright T, Bonassar L.. 2009.
  8. Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis..
    Faisal SM, Yan W, McDonough SP, Mohammed HO, Divers TJ. 2009.
  9. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Goodman L, Tsujimura K, Van de Walle G, Kim SG, Dubovi EJ, Osterrieder N. 2009.
  10. Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Syed M. Faisal, WeiWei Yan, Sean McDonough, Chao-Fu Chang, Ming-Jeng Pan. 2009.
  11. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.. Faisal SM, Yan W, McDonough SP. 2009.
  12. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression.
    McCarrel T. 2009.
  13. Genome Sequence, Comparative Analysis, and Population Genetics of the Domestic Horse (Equus Caballus) Antczak D, Wade D, et al. 2009
  14. Role of the hypoglossal nerve in equine nasopharyngeal stability
    Cheetham J, Pigott J, Hermanson J, Campoy L, Soderholm L, Thornson L, Ducharme N.

2010

  1. Whole-genome SNP association in the horse: identification of a deletion in myosin Va responsible for lavender foal syndrome Brooks SA, Gabreski N, Miller D, Brisbin A, Brown HE, Streeter C, Mezey J., Cook D, Antczak DF. 2010.
  2. Equine clinical genomics: A clinician's primer. Brosnahan MM, Brooks SA, Antczak DF. 2010
  3. Characterization of stallion PLC as a model for evaluation of male fertility. Bedford-Guaus SJ, McPartlin LA, Twomey SL, Xie J, Roberson MS. 2010
  4. Split immunological tolerance to trophoblast
    de Mestre A, Noronha L, Wagner B, Antczak D. 2010
  5. Incidence of swallowing during exercise in horses with dorsal displacement of the soft palate Pigott J, Ducharme, N, Mitchell L, Sonderholm L. 2010
  6. A transducer for measuring force on surgical sutures
    Witte T, Cheetham J, Rawlinson J, Soderholm L, Ducharme N. 2010
  7. Experimental leptospira interrogans serovar Kennewicki infection of horses
    Yan W, Faisal S, Divers T, McDonough S, Akey B, Chang YF. 2010
  8. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations
    Radcliffe C, Flaminio M, Fortier, L. 2010
  9. Maternal immune responses to trophoblast: the contribution of the horse to pregnancy immunology
    Noronha L, Antczak D. 2010

2011

  1. Effects of environmental factors on cribbing activity by horses
    Whisher L, Raum M, Pina L, Perez L, Erb H, Houpt C, Houpt K. 2011

2012

  1. Acquisitionof a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular clevage of an H7N7 influenza virus hemagglutinin
    Hammilton B, Sun X, Chung C, Whittaker G. 2012
  2. A preliminary answer to the question of whether cribbing causes salivary secretion
    Houpt K. 2012
  3. Motivation for cirbbing by horses
    Houpt K. 2012